Salisbury South based Mayne Pharma plan to double their exports to $60 million this year. To accelerate this growth they will invest $11 million instillation of a large-scale fluid bed spray coater at its Salisbury facility. Fluid bed processing technology is used to apply various polymers to drug particles to modify the rate of release of the drug when ingested.
This expansion is being supported by $4 million grant under the Federal Government Next Generation Manufacturing Investment Program which was recently announced. Other local companies which were successful include SA Structural, Ezy-Fit Hydraulics, Mayfield Engineering and BAE Systems.
Mayne Pharma expansion and growth into export market has been in-part because of the focus on R&D and investing profits back into the business. Mayneâ€™s Chief Executive Scott Richards said over the past two years the company has directed 80% of is Australian based R&D spend into the development of advanced oral drug formulations.